Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Change in Account Payables (2021 - 2023)

Werewolf Therapeutics (HOWL) has disclosed Change in Account Payables for 3 consecutive years, with -$104000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Change in Account Payables rose 88.57% to -$104000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $136000.0, a 207.09% increase, with the full-year FY2022 number at -$883000.0, down 187.69% from a year prior.
  • Change in Account Payables was -$104000.0 for Q3 2023 at Werewolf Therapeutics, up from -$616000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q2 2021 to a low of -$1.5 million in Q3 2021.
  • A 3-year average of $33181.8 and a median of -$104000.0 in 2023 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: tumbled 193.09% in 2022, then soared 242.58% in 2023.
  • Werewolf Therapeutics' Change in Account Payables stood at $651000.0 in 2021, then plummeted by 116.13% to -$105000.0 in 2022, then rose by 0.95% to -$104000.0 in 2023.
  • Per Business Quant, the three most recent readings for HOWL's Change in Account Payables are -$104000.0 (Q3 2023), -$616000.0 (Q2 2023), and $961000.0 (Q1 2023).